Healthed Going Viral Podcast featuring A/Prof Nigel Crawford

MVEC’s Associate Professor Nigel Crawford delivered the COVID-19 Update as part of the recent Healthed Australia online lecture series.

In this lecture, A/Prof Nigel Crawford discussed the following:

  • COVID booster dose
  • Myocarditis following mRNA vaccine
  • Vaccinating 5-11-year-olds with Pfizer
  • Best vaccine delivery method
  • Opening the borders – don’t forget there are many vaccine-preventable diseases (VPDs)

To listen to the lecture in full, click on the link below:
Healthed lecture series 11 November: COVID-19 Update


There's still time to register for the Clinical Vaccinology Update (CVU) 2021!

There's still time to register for the Clinical Vaccinology Update (CVU) 2021 taking place virtually on Thursday 18th and Friday 19th November.

This 2-day virtual program will allow participants to choose from keynote sessions delivered on our virtual main stage in addition to themed seminars and interactive workshops hosted by industry experts, addressing the most important issues in immunisation.

To find out more about the program and to register, please click on the link below to our Events page:
MVEC: Clinical Vaccinology Update (CVU) 2021


Reminder to register for the Clinical Vaccinology Update (CVU) 2021!

A reminder to register for the Clinical Vaccinology Update (CVU) 2021 taking place virtually on Thursday 18th and Friday 19th November.

This 2-day virtual program will allow participants to choose from keynote sessions delivered on our virtual main stage in addition to themed seminars and interactive workshops hosted by industry experts, addressing the most important issues in immunisation.

To find out more about the program and to register, please click on the link below to our Events page:
MVEC: Clinical Vaccinology Update (CVU) 2021


New educational resource: Generation Next course on COVID and kids

MVEC has collaborated with the team at Generation Next on a new resource featuring Dr Daryl Cheng to provide helpful strategies to get kids back to school safely and reduce transmission of COVID-19 in this group.

Course content reflects the combined efforts of immunisation paediatricians, adult physicians, immunisation nurses, infectious disease, and allergy specialists, as well as infection control teams. The information works to provide guidance and support for parents and communities to ensure a safe transition to a new COVID normal.

To enrol in this free course, please click on the link below:

Next Generation course: Covid and kids


CDC: Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12–18 Years

The Centers for Disease Control and Prevention (CDC) have released a report about the effectiveness of Pfizer-BioNTech mRNA vaccination against COVID-19 hospitalization among persons aged 12–18 years.

The findings in the report suggested that among hospitalized U.S. patients aged 12–18 years, vaccine effectiveness of 2 doses of Pfizer-BioNTech vaccine against COVID-19 hospitalization during June–September 2021, was 93% (95% confidence interval = 83%–97%).

Key evaluation from the report demonstrated that 2 doses of Pfizer-BioNTech vaccine were highly effective in preventing COVID-19 hospitalization among persons aged 12–18 years, reinforcing the importance of vaccination to protect U.S. youths against severe COVID-19.

To read the report in full, please click on the link below.
CDC: Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12–18 Years


Save the date for our virtual Clinical Vaccinology Update (CVU)!

MVEC are pleased to announce we will be hosting a virtual Clinical Vaccinology Update (CVU) on Thursday 18 and Friday 19 November, 2021.

Program details and ticketing information will be announced shortly via our MVEC Events Page.


New resource: The MVEC Conversation: myocarditis/pericarditis following mRNA vaccines​

Following on from our CVU mini virtual event: Matters of the heart: myocarditis and pericarditis associated with COVID-19 mRNA vaccination, The Melbourne Vaccine Education Centre is excited to announce our latest resource The MVEC Conversation: myocarditis/pericarditis following mRNA vaccines​. 

This vodcast takes a deeper look into this adverse event of special interest (AESI) and features special guest Dr. Tom Shimabukuro, the deputy director of the Immunization Safety Office at the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, in conversation with Dr Daryl Cheng and Associate Professor Nigel Crawford.

To find out more about this resource, please visit our MVEC Events page.


Commonwealth-funded places available for Nurse Immuniser course

There are limited places available for Registered Nurses (RNs) with one year of clinical experience to complete the Commonwealth-funded Nurse Immuniser short course free of charge (conditions apply).

The immunisation (Nurse immuniser) short course is based on the  National Immunisation Education Framework for Health Professionals (2017) and has been accredited by the National body for health education Health Education Services Australia (HESA).

To find out more information on this course, please click on the links below. Please note some allocations have been exhausted.
The University of Melbourne: The immunisation (Nurse immuniser) short course
Benchmarque Group Immunisation Endorsement Pathway


A recording of the 30th August CVU mini is now available

Thank you to all who attended our recent CVU miniseries event Matters of the heart: Myocarditis and pericarditis associated with COVID-19 mRNA vaccination on 30th August 2021.

This interactive webinar took an in-depth look at an important vaccine safety signal associated with COVID-19 mRNA vaccines (Pfizer and Moderna).

A recording of this event is now available via our education portal.

To access this recording please follow the link below:

CVU mini - 30th August 2021


MVEC animation: Myocarditis, pericarditis and COVID-19 vaccines

MVEC have created a new animation to help explain myocarditis and pericarditis which have been reported in a small number of individuals who have received mRNA COVID-19 vaccines Comirnaty™ and Moderna.

To view the animation and to find out more information, please refer to our myocarditis, pericarditis following COVID-19 mRNA vaccines immunisation reference page:
MVEC animation: Myocarditis and pericarditis following COVID-19 mRNA vaccines


About MVEC

The Melbourne Vaccine Education Centre (MVEC) is an educational website, developed with the aim of providing up-to-date immunisation information for both healthcare professionals and members of the public. We are based at Murdoch Children’s Research Institute (MCRI), a research organisation, and are affiliated with SAEFVIC (Surveillance of Adverse Events Following Vaccination in the Community), the Victorian Vaccine Safety Service.